In recent years, population-based studies have demonstrated an increasing trend in prescription uptake of opioids among noncancer patients [ 8 , 9 ].
← all excerpts
Opioid therapy pharmacogenomics for noncancer pain: efficacy, adverse events, and costs.
1
—
—